US regulator approves at-home version of Alzheimer’s drug Leqembi from Eisai and Biogen

  • Posted on August 29, 2025
  • By Financial Times
  • 6 Views
US regulator approves at-home version of Alzheimer’s drug Leqembi from Eisai and Biogen

Go ahead for Leqembi shot by Food and Drug Administration could help revive two companies’ sluggish sales
continue reading...

Author
Financial Times

You May Also Like